共 259 条
[1]
Buti M(2015)Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection Dig Dis Sci 60 1457-1464
[2]
Tsai N(2013)Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 468-475
[3]
Petersen J(2013)Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis Hepatology 58 1537-1547
[4]
Flisiak R(2016)PAGE-B: a risk score for hepatocellular carcinoma in Caucasians with chronic hepatitis B under a 5-year entecavir or tenofovir therapy J Hepatol 64 800-806
[5]
Gurel S(2016)Effectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year, prospective, real-world study in France Dig Dis Sci 61 3072-3083
[6]
Krastev Z(2016)Effectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year prospective field practice study in Germany Dig Dis Sci 61 3061-3071
[7]
Schall RA(2015)Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naive chronic hepatitis B patients in the real-world setting J Viral Hepat 22 504-510
[8]
Flaherty JF(2016)Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience Clin Microbiol Infect 22 95-e1-95-e7
[9]
Martins EB(2006)Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 247-254
[10]
Charuworn P(2012)Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012) Gastroenterol Hepatol 35 512-528